A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds.
Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done in a mouse model. The technique is applied via a transdermal patch.
New research suggested that Opdivo — a drug that works with the immune system to fight melanoma — is more effective than the current standard of care for patients who've had surgery to remove advanced tumors.
People with Parkinson's disease are about four times more likely to develop melanoma skin cancer and conversely, people with melanoma have a fourfold higher risk of getting Parkinson's, researchers report.